PROSOMNUS SLEEP TECHNOLOGIES

prosomnus-sleep-technologies-logo

ProSomnus designs and manufactures intraoral devices designed to help dentists get patients into therapy faster, with greater comfort, and treatment effectiveness. Its flagship products are the ProSomnus [IA] and MicrO2 Sleep, and Snore Devices. Its devices are the first, precision oral appliance therapy devices designed to enhance compliance, mitigate side effects, and enable dentists to achieve excellent patient experiences and outcomes. The company was founded in 2016 and is headquartered in Pleasanton, California.

#SimilarOrganizations #People #Financial #Website #More

PROSOMNUS SLEEP TECHNOLOGIES

Industry:
Health Care Medical Medical Device

Founded:
2016-01-01

Address:
Pleasanton, California, United States

Country:
United States

Website Url:
http://www.prosomnus.com

Total Employee:
51+

Status:
Active

Contact:
+1 844-537-5337

Email Addresses:
[email protected]

Total Funding:
39.23 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress


Similar Organizations

3nt-medical-logo

3NT Medical

3NT is disrupting Ear, Nose and Throat surgery by introducing novel single-use endoscopes purpose-built for ENT specialists.

carlsmed-logo

Carlsmed

The company manufactures and sells the aprevoโ„ข digital-to-device 3-D printed implant system for lumbar spine surgery.

perceptimed-logo

PerceptiMed

PerceptiMed develops an advanced pill identification system designed to eliminate human errors in medication dispensing in pharmacies.

portal-instruments-logo

Portal Instruments

Portal Instruments is an early stage company that offers medical device.

providence-medical-technology-logo

Providence Medical Technology

Providence Medical Technology is a privately-held medical device company focused on innovative solutions for cervical spinal conditions.

tooth-fairy-logo

Tooth Fairy

Tooth Fairy is a platform that connects patients to dentists through its patent pending technology.

Current Employees Featured

len-liptak_image

Len Liptak
Len Liptak CEO @ ProSomnus Sleep Technologies
CEO
2016-05-01

Founder


len-liptak_image

Len Liptak

Investors List

cohanzick-management-e295_image

Cohanzick Management

Cohanzick Management investment in Convertible Note - ProSomnus Sleep Technologies

crossingbridge-advisors_image

CrossingBridge Advisors

CrossingBridge Advisors investment in Convertible Note - ProSomnus Sleep Technologies

Official Site Inspections

http://www.prosomnus.com Semrush global rank: 4.62 M Semrush visits lastest month: 2.17 K

  • Host name: 104.21.93.67
  • IP address: 104.21.93.67
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "ProSomnus Sleep Technologies"

About Us - ProSomnus Sleep Technologies

About ProSomnus Sleep Technologies ProSomnus is the leading non-CPAP OSA therapyโ„ข for the treatment of Obstructive Sleep Apnea, a serious medical disease affecting over 1 billion โ€ฆSee details»

ProSomnus Sleep Technologies - Crunchbase

ProSomnus designs and manufactures intraoral devices designed to help dentists get patients into therapy faster, with greater comfort, and treatment effectiveness. Its flagship products are โ€ฆSee details»

How It Works - ProSomnus Sleep Technologies

Brian Dow is the Chief Financial Officer for ProSomnus® Sleep Technologies. Prior to joining ProSomnus in March of 2023, Mr. Dow served as Chief Financial Officer of Agendia N.V., a โ€ฆSee details»

ProSomnus® Sleep Technologies - LinkedIn

ProSomnus (NASDAQ: OSA) is the leading non-CPAP OSA therapyโ„ข for the treatment of Obstructive Sleep Apnea, a serious medical disease affecting over 1 billion people worldwide, that is associated ...See details»

ProSomnus, the Leading Non-CPAP Obstructive Sleep Apnea โ€ฆ

Nov 9, 2023 Record quarterly revenue of $7.1 million represents an increase of 41.5% year-over-year and seventh consecutive quarter of sequential revenue growthPLEASANTON, โ€ฆSee details»

ProSomnus Sleep Technologies Takes Strategic Action to Position โ€ฆ

May 9, 2024 ProSomnus Sleep Technologies, Inc. Announces Plan for $20 million in Aggregate New Financing to Support Daily Operations, Restructuring, Strategic Initiatives, and AdvocacySee details»

News Release Details - ProSomnus Sleep Technologies, Inc.

PLEASANTON, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (the โ€œCompanyโ€), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy, announced it has initiated a โ€ฆSee details»

ProSomnus® to Open New Global Headquarters and โ€ฆ

Jun 28, 2022 ProSomnus is the first manufacturer of precision, mass-customized oral appliance therapy devices to treat OSA, which affects over 74 million Americans and is associated with โ€ฆSee details»

ProSomnus® Debuts as Publicly Traded Company Focused on

Dec 6, 2022 ProSomnus is the first manufacturer of precision, mass-customized Precision Oral Appliance Therapy devices to treat OSA, which affects over 74 million Americans and is โ€ฆSee details»

Find a Provider - ProSomnus Sleep Technologies

Brian Dow is the Chief Financial Officer for ProSomnus® Sleep Technologies. Prior to joining ProSomnus in March of 2023, Mr. Dow served as Chief Financial Officer of Agendia N.V., a $60 million molecular diagnostics company, Senior โ€ฆSee details»

ProSomnus Sleep Technologies Takes Strategic Action to Position โ€ฆ

May 9, 2024 ProSomnus is the leading non-CPAP therapy for the treatment of Obstructive Sleep Apnea, a serious medical disease affecting over 1 billion people worldwide, that is associated โ€ฆSee details»

ProSomnus Files for Chapter 11 Bankruptcy for Future Viability

May 13, 2024 ProSomnus has voluntarily filed for Chapter 11 bankruptcy to restructure its debt, aiming to reduce it by approximately 60% and ensure long-term financial stability. The โ€ฆSee details»

ProSomnus Reports Strong Performance After Bankruptcy Filing

Aug 8, 2024 Summary: ProSomnus Sleep Technologies, a maker of oral appliance therapy for obstructive sleep apnea (OSA), reported record revenues of $9.1 million for Q2 2024, marking โ€ฆSee details»

ProSomnus Oral Appliances Prove Effective in OSA Treatment

Dec 19, 2023 In a six-center study assessing the efficacy, repeatability, and predictability of treating 58 moderate to severe OSA patients with ProSomnus EVO and a standard treatment โ€ฆSee details»

News Releases - ProSomnus Sleep Technologies

32,219-square-foot facility will quintuple growth and create local jobs All ProSomnus medical devices are made in Pleasanton, CA, USA SAN FRANCISCO, June 28, 2022 (GLOBE โ€ฆSee details»

ProSomnus® Debuts as Publicly Traded Company Focused on โ€ฆ

Dec 6, 2022 ProSomnus is planning to open its new design and manufacturing facility next month, which will be optimized for mass-customized manufacturing, AI-driven design and 3D โ€ฆSee details»

ProSomnus® to Present Data at SLEEP 2022, the Annual Meeting โ€ฆ

Jun 3, 2022 ProSomnus is the first manufacturer of precision, mass-customized oral appliance therapy devices to treat OSA, which affects over 74 million Americans and is associated with โ€ฆSee details»

Ex-SPAC Sleep Apnea Device Maker ProSomnus Files for Bankruptcy

May 8, 2024 ProSomnus Inc. filed for Chapter 11 bankruptcy on Tuesday less than 18 months after it debuted as a public company via a combination with a special-purpose acquisition โ€ฆSee details»

ProSomnus Oral Appliances Perform Better Than You Think, Study โ€ฆ

Jun 23, 2022 ProSomnus also recently shared results of a study it conducted on its ProSomnus EVO Sleep and Snore Device. Also presented at SLEEP 2022 , data from a cohort of 55 โ€ฆSee details»

linkstock.net © 2022. All rights reserved